Weight discrimination and up-to-date breast and cervical cancer screening in US women.
1/5 보강
[OBJECTIVE] Little research has investigated whether people's experiences with weight-related discrimination serve as a barrier to cancer screening.
- 표본수 (n) 909
APA
Gerend MA, Wilkinson LJ, et al. (2026). Weight discrimination and up-to-date breast and cervical cancer screening in US women.. Preventive medicine, 202, 108470. https://doi.org/10.1016/j.ypmed.2025.108470
MLA
Gerend MA, et al.. "Weight discrimination and up-to-date breast and cervical cancer screening in US women.." Preventive medicine, vol. 202, 2026, pp. 108470.
PMID
41285225 ↗
Abstract 한글 요약
[OBJECTIVE] Little research has investigated whether people's experiences with weight-related discrimination serve as a barrier to cancer screening. This study examined the association between weight discrimination and receipt of up to date (UTD) cervical and breast cancer screening in a demographically diverse sample of US women with representation across the body mass index (BMI) spectrum.
[METHODS] In 2021, women aged 25-64 years completed an online survey. Multivariable logistic regression assessed the association between perceived weight discrimination (as measured by the Stigmatizing Situations Survey-Brief) and self-reported cervical (N = 909) and breast cancer screening (N = 442), in Black and White women, adjusting for BMI and demographic characteristics.
[RESULTS] Among White women, more frequent exposure to weight discrimination was associated with significantly lower odds of UTD cervical cancer screening, AOR = 0.78; 95 % CI = 0.62, 0.97, and breast cancer screening, AOR = 0.53, 95 % CI = 0.36, 0.78; for each unit increase on the weight discrimination scale, the odds of screening decreased by approximately 25-50 %. In contrast, weight discrimination was not significantly associated with either type of screening among Black women.
[CONCLUSIONS] Previous experiences with weight discrimination may deter some women from seeking routine cancer screening. Strategies for mitigating the harmful consequences of weight-related discrimination in health care settings are needed.
[METHODS] In 2021, women aged 25-64 years completed an online survey. Multivariable logistic regression assessed the association between perceived weight discrimination (as measured by the Stigmatizing Situations Survey-Brief) and self-reported cervical (N = 909) and breast cancer screening (N = 442), in Black and White women, adjusting for BMI and demographic characteristics.
[RESULTS] Among White women, more frequent exposure to weight discrimination was associated with significantly lower odds of UTD cervical cancer screening, AOR = 0.78; 95 % CI = 0.62, 0.97, and breast cancer screening, AOR = 0.53, 95 % CI = 0.36, 0.78; for each unit increase on the weight discrimination scale, the odds of screening decreased by approximately 25-50 %. In contrast, weight discrimination was not significantly associated with either type of screening among Black women.
[CONCLUSIONS] Previous experiences with weight discrimination may deter some women from seeking routine cancer screening. Strategies for mitigating the harmful consequences of weight-related discrimination in health care settings are needed.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Adult
- Female
- Humans
- Middle Aged
- Black or African American
- Body Mass Index
- Breast Neoplasms
- Early Detection of Cancer
- Mass Screening
- Surveys and Questionnaires
- United States
- Uterine Cervical Neoplasms
- Weight Prejudice
- White
- Cancer screening
- Obesity
- Social determinants of health
- Weight prejudice
- Women
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.